ARTICLE | Clinical News
ReoPro abciximab: Phase IV started
December 21, 2009 8:00 AM UTC
Atrium Medical Corp. (Hudson, N.H.) began a single-blind, international post-marketing study to evaluate percutaneous coronary intervention (standard of care), intracoronary (IC) infusion of ReoPro v...